切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (06) : 236 -240. doi: 10.3877/cma.j.issn.1674-0807.2007.06.015

综述

TNF-α 与肿瘤发生发展关系的研究进展
崔力方1, 郭晓静1, 付丽1,   
  1. 1.300060 天津医科大学附属肿瘤医院乳腺病理科、教育部乳腺癌防治重点实验室
  • 收稿日期:2007-11-10 出版日期:2007-12-01
  • 通信作者: 付丽
  • 基金资助:
    国家自然科学基金资助项目(30470667,30600225)

Advances in study of the relationship of TNF-α with development and progression of tumors

Li-fang CUI, Xiao-jing GUO, Li FU   

  • Received:2007-11-10 Published:2007-12-01
  • Corresponding author: Li FU
引用本文:

崔力方, 郭晓静, 付丽. TNF-α 与肿瘤发生发展关系的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(06): 236-240.

Li-fang CUI, Xiao-jing GUO, Li FU. Advances in study of the relationship of TNF-α with development and progression of tumors[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(06): 236-240.

[1]
Pfitzenmaier J, Vessella R, Higano C S, et al. Elevation of cytokine levels in cachectic patients with prostate carcinoma.Cancer,2003,97:1211 -1216.
[2]
Karayiannakis A J, Syrigos K N, Polychronidis A,et al. Serum level of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Res, 2001, 21:1355 - 1358.
[3]
Yoshida N, Ikemoto S,Narita K,et al. Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer,2002,86:1396 -1400.
[4]
Ferrajoli A, Keating M J, Manshouri T, et al. The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia. Blood, 2002, 100:1215 - 1219.
[5]
Balkwill F. Tumor necrosis factor or tumor promoting factor?Cytokine Growth Factor Rev,2002,13:135 -141.
[6]
Jeong P, Kim E J, Kim E G, et al. Association of bladder tumor and GA genotype of 308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression. Urology,2004,64:1052 -1056.
[7]
Shih C M, Lee Y L, Chiou H L, et al . Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer,2006,52:15 -20.
[8]
Komori A, Yatsunami J, Suganuma M,et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res,1993,53:1982 -1985.
[9]
Suganuma M, Okabe S, Marino M W,et al. Essential role of tumor necrosis factor alpha in tumor promotion as revealed by TNF-alpha-deficient mice.Cancer Res, 1999, 59:4516 - 4518.
[10]
Orosz P, Echtenacher B, Falk W, et al . Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med,1993,177:1391 -1398.
[11]
Choo M K, Sakurai H, Koizumi K, et al . Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellar signal-regulated kinase pathway. Cancer Lett,2005,230:47 -56.
[12]
Luo J L, Maeda S, Hsu L C,et al. Inhibition of NF-kappa B in cancer cells converts inflammation- induced tumor growth mediated by TNF-alpha to TRAIL-mediated tumor regression.Cancer Cell,2004,6:297 -305.
[13]
Wheelhouse N M, Chan Y S, Gillies S E, et al. TNF-alpha induced DNA damage in primary murine hepatocytes. Int J Mol Med,2003,12:889 -894.
[14]
Meeta J, Nicholas F L, Lawrence J B,et al. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.2000,60:184 -190.
[15]
Arnott C H, Scott K A, Moore R J, et al. Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene,2002,21:4728 -4738.
[16]
Rubio M F, Werbajh S, Cafferata E G,et al. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factorkappa B. Oncogene,2006,25:1367 -1377.
[17]
Berry K K, Varney M L, Dave B J,et al. Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines. Int J Gynecol Cancer,2001,11:54 -60.
[18]
Elaraj D M, Weinreich D, Varghese S,et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res,2006,12:1088 -1096.
[19]
Han Y P, Tuan T L,Wu H,et al . TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci,2001,114( Pt 1) :131 - 139.
[20]
Han Y P, Nien Y D, Gamer W L,et al. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissueassociated chymotrypsin-like proteinase. J Biol Chem,2002,277:27319 -27327.
[21]
Zhang Z L, Liu Z S, Sun Q. Effects of thalidomide on angiogenesis and tumor growth and metastasis of human hepatocellular carcinoma in nude mice. World J Gastroenterol,2005,11:216 - 220.
[22]
Nabors L B, Suswan E, Hunag Y,et al. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells:a role for RNA stabilization and HuR. Cancer Res,2003,63:4181 -4187.
[23]
Barshishat M, Ariel A, Cahalon L,et al. TNF-alpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells. Clin Exp Metastasis,2002,19:3 2 7 - 3 3 7.
[24]
Khatib A M, Kontogiannea M, Fallavollita L, et al . Rapid induction of cytokine and E-selectin expression in the liver response to metastasis tumor cells. Cancer Res,1999,59:1356 -1361.
[25]
Chen M, Geng J G. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis,and cancer growth and metastasis. Arch Immunol Ther Exp(Warsz) ,2006,54:75 -84.
[26]
Zhu N, Eves P C, Katerinaki E, et al . Melanoma cell attachment, invasivasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone. J Invest Dermatol, 2002, 119:1165 - 1171 .
[27]
Moss M A, Zimmer S, Anderson K W. Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers. Anticancer Res,2000,20:1425 -1433.
[28]
Prevost Blondel A, Roth E, Rosenthal F M,et al. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J Immunol,2000,164:3645 - 3651.
[29]
Baxevanis C N, Voutsas I F, Tsitsilonis O E,et al. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice. Eur J Immunol,2000,30:1957 -1966.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[13] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[14] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[15] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
阅读次数
全文


摘要